Selvita S.A. — M&A Activity 2024

May 7, 2024

Report Content Closing of an acquisition of PozLab sp. z o.o. by Selvita S.A.

The Management Board of Selvita S.A., headquartered in Krakow(_quot;Issuer_quot;), in reference to the current report No. 4/2024 dated March27, 2024, hereby informs that on May 6, 2024, the Issuer, as the buyer,entered into a purchase agreement (_quot;Agreement_quot;, _quot;Transaction_quot;) for theacquisition of 100% of the shares ("Shares_quot;) in PozLab sp. z o.o.,headquartered in Poznan (_quot;PozLab_quot;) with Younick Technology Park sp. zo.o., headquartered in Złotniki, as the seller (_quot;Seller_quot;), after thefulfilment of all conditions precedent indicated in the preliminaryconditional agreement including in particular:

i. obtaining the consent of the National Centre for Research andDevelopment (in Polish: Narodowe Centrum Badań i Rozwoju) for theacquisition of all Shares by the Issuer; and

ii. completion of the capital restructuring process of the Seller'sgroup by concluding, between PozLab and a third party designated by theSeller, an agreement for the sale of 100% of the shares in AppliedManufacturing Science sp. z o.o., a subsidiary of PozLab.

The Issuer acquired PozLab Shares for a total price of PLN 25,000,000,with PLN 21,000,000 paid on the Transaction's closing date. The Issuerwill retain the amount of PLN 4,000,000 for a period of up to 12 monthsfrom the date of closing the Transaction as security for any,specifically enumerated in the preliminary agreement, events or claimsby third parties against PozLab, as well as to secure settlementsrelated to price adjustments. The acquisition of the Shares was financedfrom the Issuer's own funds.

Acquisition of CDMO (Contract Development and ManufacturingOrganization) will strengthen the Issuer's offering in the field ofsmall molecule drug development and allow it to enter a completely new,highly attractive area related to drug development services for earlyclinical trials.

Disclaimer: This English language translation has been prepared solelyfor the convenience of English-speaking readers. Despite all the effortsdevoted to this translation, certain discrepancies, omissions, orapproximations may exist. In case of any differences between the Polishand the English versions, the Polish version shall prevail. SelvitaS.A., its representatives, and employees decline all responsibility inthis regard.